Isobe H, Okajima K, Uchiba M, Mizutani A, Harada N, Nagasaki A, Okabe K
Department of Laboratory Medicine, Kumamoto University School of Medicine, Kumamoto, Japan.
Circulation. 2001 Sep 4;104(10):1171-5. doi: 10.1161/hc3501.093799.
Excessive production of nitric oxide (NO) by the inducible isoform of NO synthase (iNOS) is critically involved in endotoxin (ET)-induced hypotension. Tumor necrosis factor-alpha (TNF-alpha) plays an important role in induction of iNOS. Because activated protein C (APC), a physiological anticoagulant, inhibits TNF-alpha production, it might prevent hypotension by inhibiting excessive production of NO. In this study, we examined this possibility using a rat model of septic shock.
Intravenous administration of APC prevented both ET-induced hypotension and the increases in plasma levels of NO(2)(-)/NO(3)(-). The hypotension was also inhibited when APC was administered 30 minutes after ET administration. APC inhibited the increases in lung levels of iNOS activity by inhibiting expression of iNOS mRNA in animals given ET. APC significantly inhibited the increases in lung tissue levels of TNF-alpha and expression of TNF-alpha mRNA in animals given ET. Neither DEGR-F.Xa, a selective inhibitor of thrombin generation, nor DIP-APC, an active site-blocked APC, showed any effect on these ET-induced changes. Both inhibition of TNF-alpha production by leukocytopenia and treatment with anti-rat TNF-alpha antibody produced effects similar to those induced by APC. Aminoguanidine, a selective inhibitor of iNOS, inhibited both the hypotension and the increases in plasma levels of NO(2)(-)/NO(3)(-) in this animal model.
These observations strongly suggest that APC inhibits iNOS induction by decreasing TNF-alpha production, leading to the prevention of ET-induced hypotension. Furthermore, such effects of APC were not dependent on its anticoagulant effects but rather on its serine protease activity.
诱导型一氧化氮合酶(iNOS)过度产生一氧化氮(NO)在内毒素(ET)诱导的低血压中起关键作用。肿瘤坏死因子-α(TNF-α)在iNOS的诱导中起重要作用。由于活化蛋白C(APC)是一种生理性抗凝剂,可抑制TNF-α的产生,因此它可能通过抑制NO的过度产生来预防低血压。在本研究中,我们使用脓毒性休克大鼠模型检验了这种可能性。
静脉注射APC可预防ET诱导的低血压以及血浆中NO₂⁻/NO₃⁻水平的升高。在ET给药30分钟后给予APC时,低血压也受到抑制。APC通过抑制给予ET的动物中iNOS mRNA的表达来抑制肺中iNOS活性水平的升高。APC显著抑制给予ET的动物肺组织中TNF-α水平的升高以及TNF-α mRNA的表达。凝血酶生成的选择性抑制剂DEGR-F.Xa和活性位点被阻断的APC(DIP-APC)对这些ET诱导的变化均无任何作用。白细胞减少对TNF-α产生的抑制以及用抗大鼠TNF-α抗体治疗产生的效果与APC诱导的效果相似。在该动物模型中,iNOS的选择性抑制剂氨基胍可抑制低血压以及血浆中NO₂⁻/NO₃⁻水平的升高。
这些观察结果强烈表明,APC通过减少TNF-α的产生来抑制iNOS的诱导,从而预防ET诱导的低血压。此外,APC的这种作用不依赖于其抗凝作用,而是依赖于其丝氨酸蛋白酶活性。